Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona Grimson

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Neurological Disorders|July 2, 2026
Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensionsVera Bril, Artur Drużdż, Julian Grosskreutz, et al.
Therapeutic Advances in Neurological Disorders|September 24, 2024
Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysisGuillemette de la Borderie, Damien Chimits, Babak Boroojerdi, et al.
International Journal of STD & AIDS|June 22, 2021
Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimensChinyere Okoli, Achim Schwenk, Matthew Radford, et al.
Lung Cancer Management|June 4, 2021
Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital databaseMarta Soares, Luís Antunes, Patrícia Redondo, et al.
BMC Pulmonary Medicine|September 11, 2020
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiativeMarta Soares, Luís Antunes, Patrícia Redondo, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Therapeutic Advances in Neurological Disorders|July 2, 2026
Long-term use of rozanolixizumab in generalised myasthenia gravis: final pooled analysis of the phase III MycarinG study and two open-label extensionsVera Bril, Artur Drużdż, Julian Grosskreutz, et al.
Therapeutic Advances in Neurological Disorders|September 24, 2024
Maintenance of zilucoplan efficacy in patients with generalised myasthenia gravis up to 24 weeks: a model-informed analysisGuillemette de la Borderie, Damien Chimits, Babak Boroojerdi, et al.
International Journal of STD & AIDS|June 22, 2021
Using Climate-HIV to describe real-world clinical outcomes for people living with HIV taking dolutegravir-based regimensChinyere Okoli, Achim Schwenk, Matthew Radford, et al.
Lung Cancer Management|June 4, 2021
Treatment and outcomes for early non-small-cell lung cancer: a retrospective analysis of a Portuguese hospital databaseMarta Soares, Luís Antunes, Patrícia Redondo, et al.
BMC Pulmonary Medicine|September 11, 2020
Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiativeMarta Soares, Luís Antunes, Patrícia Redondo, et al.
Pageof 2